Status:

COMPLETED

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

Lead Sponsor:

University of Utah

Collaborating Sponsors:

VA Salt Lake City Health Care System

University of Pennsylvania

Conditions:

Hypertension

COVID

Eligibility:

All Genders

18+ years

Brief Summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, enters type II pneumocytes using angiotensin-converting enzyme 2 (ACE2). It is unclear whether ACE inh...

Detailed Description

The Coronavirus Disease 2019 (COVID-19) pandemic has killed \>129,000 Americans as of June 30, 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, e...

Eligibility Criteria

Inclusion

  • Positive SARS-CoV-2 test in the outpatient setting (Aim 1) or hospitalized for COVID-19 (Aim 2)
  • Meet continuous enrollment criteria (≥1 inpatient or any outpatient encounter in each of the two, six-month periods during the 365 days prior to the index date)
  • Do not have data inconsistencies (test patients, not Veterans, multiple death dates in data, or not alive on index date)
  • Diagnosed with hypertension at any point prior to the index date
  • Had at least one prescription dispensed for an antihypertensive medication in the 90 days prior to the index date

Exclusion

  • Aim 1.1 and 2.1 (ACEI/ARB vs. non-ACEI/ARB comparison): diagnosed with a compelling indication for ACEI/ARB at any point prior to the index date (i.e., diabetes, stroke, chronic kidney disease, heart failure with reduced ejection fraction, or coronary heart disease)
  • Aim 1.2 and 2.2 (ACE vs. ARB comparison): prescription fills for both an ACEI and an ARB in the 90 days prior to the index date; no prescription fill for an ACEI or an ARB in the 90 days prior to the index date

Key Trial Info

Start Date :

January 19 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2020

Estimated Enrollment :

22213 Patients enrolled

Trial Details

Trial ID

NCT04467931

Start Date

January 19 2020

End Date

December 31 2020

Last Update

April 28 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Utah

Salt Lake City, Utah, United States, 84112